Tekla Capital Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-203,103
| Closed | -$3.73M | – | 206 |
|
|
2020
Q3 | $3.73M | Hold |
203,103
| – | – | 0.14% | 118 |
|
|
2020
Q2 | $3.63M | Buy |
203,103
+91,440
| +82% | +$1.63M | 0.14% | 124 |
|
|
2020
Q1 | $1.81M | Sell |
111,663
-13,483
| -11% | -$219K | 0.08% | 139 |
|
|
2019
Q4 | $2.25M | Sell |
125,146
-70,000
| -36% | -$1.26M | 0.09% | 147 |
|
|
2019
Q3 | $3.95M | Sell |
195,146
-96,273
| -33% | -$1.95M | 0.17% | 97 |
|
|
2019
Q2 | $6.44M | Sell |
291,419
-23,743
| -8% | -$525K | 0.26% | 80 |
|
|
2019
Q1 | $4.3M | Hold |
315,162
| – | – | 0.17% | 101 |
|
|
2018
Q4 | $2.85M | Buy |
315,162
+165,342
| +110% | +$1.5M | 0.12% | 111 |
|
|
2018
Q3 | $2.47M | Sell |
149,820
-91,023
| -38% | -$1.5M | 0.09% | 134 |
|
|
2018
Q2 | $3.37M | Buy |
240,843
+59,820
| +33% | +$838K | 0.13% | 110 |
|
|
2018
Q1 | $2M | Buy |
181,023
+91,023
| +101% | +$1.01M | 0.08% | 135 |
|
|
2017
Q4 | $792K | Hold |
90,000
| – | – | 0.03% | 148 |
|
|
2017
Q3 | $1.2M | Hold |
90,000
| – | – | 0.04% | 134 |
|
|
2017
Q2 | $1.29M | Hold |
90,000
| – | – | 0.05% | 127 |
|
|
2017
Q1 | $1.9M | Hold |
90,000
| – | – | 0.07% | 114 |
|
|
2016
Q4 | $2.53M | Buy |
+90,000
| New | +$2.53M | 0.11% | 96 |
|